CSL shares surge as profit jumps to $2.8 billion

This post was originally published on this site

Australian biotech giant CSL Limited has lifted its full year profit to $US1.91 billion ($2.81 billion), up 17 per cent from last year. The company said on Wednesday that its revenue in the year to June 30 jumped 11 per cent to $US8.41 billion, from increased …

Click here to read full article